Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGA-2: Norepinephrine vs Phenylephrine for Postoperative AKI Prevention
NCT06802224Phase 4Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Apr 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of norepinephrine, phenylephrine in hypotension, acute kidney injury (AKI), sponsored by University of California, San Francisco. Started Apr 2025; status: recruiting.
02
Drugs
norepinephrinephenylephrine
03
Conditions
hypotensionacute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06802224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06802224.